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VIEWPOINT
A Coming Disruption in Pharmacy?
Frank Romanelli, PharmD, MPH, Timothy S. Tracy, PhD
University of Kentucky College of Pharmacy, Lexington, Kentucky

The 1990s were a tumultuous time for academic
pharmacy with assorted colleges and schools offering
various iterations of pharmacy degree programs, from
a 5-year, entry-level baccalaureate degree to 6-year doctor of pharmacy (PharmD) track-in programs to the traditional 2-year postbaccalaureate PharmD. After much
debate and despite a lack of clear consensus on the future
training requirements for pharmacists, the profession endorsed an entry-level, 6-year PharmD degree as the sole
credential for pharmacy practice. Prospectively, beginning with students entering pharmaceutical studies in
2000, the baccalaureate degree became insufficient to
practice pharmacy in the United States.
Much has changed in both health care and academic
landscapes since the early debates surrounding pharmacy
academic degrees. It seems only yesterday that the Pew
Health Professions Commission recommended closing
20 to 25 percent of US pharmacy schools with a corollary
reduction of pharmacy graduates by 10 to 25 percent by
2005.1 The commission surmised that these changes
would be needed in order to avoid an excess of 40 000
pharmacists. The surplus was projected to be an inevitable
result of automation and centralization of drug-dispensing
functions. Since the 1995 Pew report, the profession has
undergone manic workforce swings marked initially
with significant growth and followed by a rebounding
contraction. These fluctuations were followed in short
order by a significant and somewhat sustained growth in
the number of US schools and colleges of pharmacy. At
the same time as the increase in number of schools, existing and established schools almost unilaterally expanded
class sizes to varying degrees.2,3 Recently, in most areas
of the United States, the workforce demand for pharmacists
has been contracting, in contrast to the still increasing
number of graduates. By 2016, 14 000 to 15 000 PharmD
students are expected to enter the workforce.4 This will
represent more than double the number of graduates produced in 2001, leading some to predict a looming joblessness crisis for the profession.4
In addition to the obvious effects of a pharmacist surplus, the academy should be cognizant of additional forces
that may shape pharmacy practice. A rapidly evolving
health care environment, increasingly influenced by factors

such as advances in technology and health care reform,
may equally, if not more significantly, influence pharmacy. The confluence of external health care factors
and a surplus of pharmacists may herald seismic, significant, and sustained changes for the profession. We argue
that both subtle and obvious signs of a disruption may
already be evident. Salaries across the profession, especially within the ambulatory/community sector, have
largely stabilized. Emphasis in the ambulatory sector
seems to be increasingly moving toward medication therapy management and associated reimbursement programs with a de-emphasis on dispensing and associated
fees. Certainly, continuing reductions in dispensing fees
paid by pharmacy benefit management organizations is
evidence of this; in some cases a $0 dispensing fee is
employed. Pharmacy technicians continuing to assume
greater roles in drug dispensing is congruent with ever
growing credentialing efforts across the United States.5
Bar-coded robotics dispensing systems continue to proliferate in hospital systems and are an increasing part of
community pharmacy, as well. Finally, progressively
complicated and costly drug regimens are creating an
emerging market for specialty therapeutics that will require highly focused expertise and experience.
The current model of using over-qualified pharmacy
practitioners for the sole purpose of drug dispensing may
be replaced by a new 2-tier paradigm involving “dispensing” and “nondispensing” pharmacists. Dispensing pharmacists would supervise a core of pharmacy technicians
that provide high-volume, product-focused services. As
pharmacy technician credentialing continues to increase,
these “super technicians,” combined with robotic systems, might even replace the functions of the dispensing
pharmacist. Nondispensing, clinically proficient pharmacists, many with residency training and appropriate credentials, would focus on clinical implications of drug
therapy, health care outcomes, and other direct patient
care-related activities. These clinicians might also meet
current primary care gaps within the United States by
managing basic and chronic care of patient populations.
The substantial patient assessment and care management
training occurring at many pharmacy schools prepares
pharmacists to assume this more significant patient care
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role. A significant salary differential, commensurate with
credentialing, training expectations, and differences in
clinical service expectations might develop between
these 2 “classes” of pharmacists. Subtle undertones of
this change may be reaching students, as most schools
can attest to significant increases in postgraduate year 1
(PGY1) and 2 (PGY2) program interest.6 Competition
for these limited positions continues to escalate at a remarkable pace as does the number of applicants seeking
certification through the Board of Pharmacy Specialties.7
Many within the academy continue to question the
wisdom associated with the decision to adopt the entrylevel PharmD. The potential arrival of a 2-tier system might
represent a back-to-the-future moment for the profession,
echoing the bachelor of science in pharmacy/postbaccalaureate PharmD era. Some might debate whether the 2-tier
system would be a positive or negative proposition for the
profession. Regardless, such change would represent
a significant disruption in the profession—that is, a complete bifurcation in how we think, behave, go about business, and learn. Disruptions in a process, organization,
even a profession are typically associated with improved
efficiency, new output, creativity, and tangible gains.
However, disruptions are simultaneously inventive and
caustic. In any disruption, there will be consequences
for practitioners, students, and graduates.
Schools should be keenly aware of subtle and obvious changes occurring within pharmacy. Particular attention should be paid to the future role of pharmacy, if and
when a disruption occurs. Now more than ever, curricular
administrators must be creative and steadfast in their approaches to pedagogy and curricular design. If the profession moves towards a 2-tier system, there will be

significant collateral damage to institutions not properly
positioned, prepared, or poised to adapt. Certainly, not all
schools’ financial models support a positive return on investment for graduates who would assume a dispensing
pharmacist role that pays significantly less than current
salaries. The academy might be well served to begin discussions about possible disruptions within the profession
and how to adapt. Ignoring the signs and symptoms of
change would be a disservice to our educational institutions, students, and alumni.
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